Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35


The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.

Henriksson M, Epstein DM, Palmer SJ, Sculpher MJ, Clayton TC, Pocock SJ, Henderson RA, Buxton MJ, Fox KA.

Heart. 2008 Jun;94(6):717-23.


Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.

Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.

Health Technol Assess. 2005 Jul;9(27):iii-iv, ix-xi, 1-158. Review.


Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.


A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.

Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, Moore D.

Health Technol Assess. 2006 Jun;10(20):iii-iv, ix-113. Review.


Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.

Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B, Wallentin L; FIR Collaboration..

J Am Coll Cardiol. 2010 Jun 1;55(22):2435-45. doi: 10.1016/j.jacc.2010.03.007. Review.


'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.


Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom.

McKenna C, Hawkins N, Claxton K, McDaid C, Suekarran S, Light K, Chester M, Cleland JG, Woolacott N, Sculpher M.

Int J Technol Assess Health Care. 2010 Apr;26(2):175-82. doi: 10.1017/S0266462310000073. Review.


Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.

Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. Review.


How should we diagnose suspected deep-vein thrombosis?

Goodacre S, Stevenson M, Wailoo A, Sampson F, Sutton AJ, Thomas S.

QJM. 2006 Jun;99(6):377-88. Review.


What is the best imaging strategy for acute stroke?

Wardlaw JM, Keir SL, Seymour J, Lewis S, Sandercock PA, Dennis MS, Cairns J.

Health Technol Assess. 2004 Jan;8(1):iii, ix-x, 1-180. Review.


Structural neuroimaging in psychosis: a systematic review and economic evaluation.

Albon E, Tsourapas A, Frew E, Davenport C, Oyebode F, Bayliss S, Arvanitis T, Meads C.

Health Technol Assess. 2008 May;12(18):iii-iv, ix-163. Review.


The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A.

Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. Review.


Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population?

Elliott RA, Hooper L, Payne K, Brown TJ, Roberts C, Symmons D.

Rheumatology (Oxford). 2006 May;45(5):606-13. Review.


Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease.

Nicholson T, McGuire A, Milne R.

BMC Cardiovasc Disord. 2001;1:2. Review.


Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events.

Plosker GL, Lyseng-Williamson KA.

Pharmacoeconomics. 2007;25(12):1031-53. Review.


Systematic review: comparing routine and selective invasive strategies for the acute coronary syndrome.

Qayyum R, Khalid MR, Adomaityte J, Papadakos SP, Messineo FC.

Ann Intern Med. 2008 Feb 5;148(3):186-96. Review.


Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis.

Bravo Vergel Y, Palmer S, Asseburg C, Fenwick E, de Belder M, Abrams K, Sculpher M.

Heart. 2007 Oct;93(10):1238-43. Review.


Acute coronary syndromes: unstable angina/non-ST elevation myocardial infarction.

Bhatheja R, Mukherjee D.

Crit Care Clin. 2007 Oct;23(4):709-35, v. Review.


Early angiography in patients with chronic kidney disease: a collaborative systematic review.

Charytan DM, Wallentin L, Lagerqvist B, Spacek R, De Winter RJ, Stern NM, Braunwald E, Cannon CP, Choudhry NK.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1032-43. doi: 10.2215/CJN.05551008. Review.

Items per page

Supplemental Content

Support Center